98%
921
2 minutes
20
Exposure to atmospheric aerosols threatens human health and is yet to be effectively addressed globally. Aerosol toxicity strongly depends upon components whose chemical profiles and concentrations can constantly evolve throughout atmospheric transformation, inhalation, distribution, metabolism, and excretion. Despite the abundant studies on aerosol components and their toxic effects, the dynamics in component concentrations and related biological effects from air to the body remain unclear. Here, we propose a conceptual toxicokinetic framework to mathematically deduce the bioavailable concentration from the changing bulk concentration of aerosol constituents in the atmosphere. The biological effects of single or multiple components are further predicted via toxicodynamic modeling according to their bioavailable concentrations. Atmospheric concentrations of toxic composition can in turn be regulated by risk-based guidelines, aiming to alleviate toxic effects. This perspective demonstrates how serial toxicokinetic-toxicodynamic equations bridge the knowledge gap between ambient aerosols and associated toxic effects in human bodies. The prediction from an inhalation perspective also allows connecting with the exposomes from aggregate exposure pathways. We call for the development of the model validity and integrate quantitative adverse outcome pathways to apply for exposure-disease modeling, providing novel insights into air quality policymaking and public health management.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.est.5c00751 | DOI Listing |
Med Oncol
September 2025
Venom and Biotherapeutics Molecules Laboratory, Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Neuropeptide Y (NPY) and the voltage-gated potassium channel Kv1.3 are closely associated with breast cancer progression and apoptosis regulation, respectively. NPY receptors (NPYRs), which are overexpressed in breast tumors, contribute to tumor growth, migration, and angiogenesis.
View Article and Find Full Text PDFActa Parasitol
September 2025
Région du Centre, Université Joseph Ki-Zerbo, Rue Thomas Sankara, O3 BP 7021, Ouagadougou, Burkina Faso.
Introduction: The objective of the World Health Organization is to achieve the interruption of human African trypanosomiasis (HAT) transmission by 2030.
Methods: This review aims to update knowledge on HAT, through a synthesis on the epidemiology, diagnostic tools and drugs of HAT.
Results: From 1960 to 2024 approximately 132,063 cases of HAT have been reported across Africa.
Vet Res Commun
September 2025
Department of Aquaculture, Faculty of Fisheries, Cukurova University, Adana, Turkey.
This study evaluated how dietary black seed oil (Nigella sativa L.) against the diazinon waterborne toxicity on Nile tilapia (Oreochromis niloticus), focusing on growth performance, hematological and biochemical parameters as well as oxidative stress markers and histological changes. A 40-day feeding trial was carried out using four experimental groups: Group 1 (control group), Group 2 (N.
View Article and Find Full Text PDFBull Environ Contam Toxicol
September 2025
Laboratorio de Ecotoxicología, Instituto de Investigaciones Marinas y Costeras (IIMYC), Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad Nacional de Mar del Plata (CONICET- UNMDP), Dean Funes 3350, 7600, Mar del Plata, Buenos Aires, Argentina.
The potential genotoxicity of the fungicide tebuconazole (TBZ) was evaluated in the freshwater fish Jenynsia lineata when exposed to 0.005, 0.05, 0.
View Article and Find Full Text PDFAnn Hematol
September 2025
Excellence Center for Comprehensive Cancer (ECCCC), King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Despite therapeutic advances, multiple myeloma (MM) remains incurable, especially in relapsed/refractory (R/R) cases. B-cell maturation antigen (BCMA) is a key target for novel immunotherapies, including chimeric antigen receptor T-cell (CAR-T) therapies and bispecific T-cell engagers (BiTEs), which vary in efficacy, toxicity, and accessibility. To compare the efficacy and safety of BCMA-directed CAR-T therapies and BiTEs in R/R MM through a systematic review and meta-analysis.
View Article and Find Full Text PDF